To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

There is both good news and bad news about prostate cancer screening. First, the bad news: the blood test involved, which measures a compound called prostate-specific antigen (PSA), is too inaccurate.

A major review of nearly 800,000 men has found prostate cancer screening using a specific test is likely to reduce deaths ...

Although blood test reduces deaths by two for every 1,000 men screened, many could face unnecessary treatment ...

International experts have recommended quick and targeted MRI scans for prostate cancer screening. Some 21 urologists, radiologists and pathologists from Europe and the US agreed an "expert consensus ...

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...

The newly developed urine test helps identify which prostate cancer patients need a biopsy and which can safely skip the ...

Prostate cancer screening could save thousands of lives a year and should be made an option for the vast majority of men, a ...

A new at-home saliva test could help identify men with a high risk of prostate cancer more accurately than blood tests, leading to earlier diagnosis and more successful treatment. Prostate cancer is ...